2 reports

A team at UCLA was awarded $##. ## million to develop a way to genetically modify blood stem cells to help make the immune system resistant to the AIDS virus as a potential treatment and even cure for HIV/ AIDS.

  • Healthcare
  • Therapy
  • Type 1 Diabetes
  • United States
  • ViaCyte, Inc.
  • TYPE 1 DIABETES (JUVENILE DIABETES) - PIPELINE BY GEROPHARM, H2 2016
  • TYPE 1 DIABETES (JUVENILE DIABETES) - PIPELINE BY GILEAD SCIENCES, INC., H2 2016

The company offers products in various therapeutic areas including cardiovascular, respiratory, inflammation, liver diseases, cancer and HIV/ AIDS.

  • Pharmaceutical
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Company
  • Product Initiative